Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

How Rheumatologists Can Connect with Congress during August Recess

Staff  |  July 1, 2013

Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices

Rheumatology Drug Research Should Focus on Particular Groups of Patients

Deborah Levenson  |  July 1, 2013

An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment

California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis

Stephanie Cajigal  |  July 1, 2013

Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says

What Rheumatologists Need to Know About the Physician Payment Sunshine Act

Steven M. Harris, Esq.  |  July 1, 2013

The federal act mandates transparency within physician–industry relationship

Researchers Explore HLA-B27’s Role in the Development of Spondylitis

Will O’Brien, MD  |  June 14, 2013

New research reports on the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation. (posted June 27, 2013)

Can Lubricating Joints Prevent Osteoarthritis?

Deepak Rao MD, PhD  |  June 13, 2013

 Proteoglycan 4 (Prg4), also known as lubricin, could slow the process of cartilage destruction in osteoarthritis. (posted June 13, 2013)

Small Fiber Function May Be Linked to Fibromyalgia

Kurt Ullman  |  June 13, 2013

Researchers show, for the first time, that small fiber function and morphology is impaired in patients with fibromyalgia.  (posted June 18, 2013)

Th17 May Contribute to Bone Destruction by Modifying Osteoclasts

Lara C. Pullen, PhD  |  June 3, 2013

New research describes the role of RANKL-expressing Th17 cells in inflammatory bone destruction. (posted June 3, 2013)

Advances in Genomics, Bioinformatics Draw New Insights From the Human Genome

Sheri M. Krams, PhD, and Jonathan S. Bromberg, MD, PhD  |  June 1, 2013

Widely held belief that large segments of the human genome consist of ‘junk DNA’ is incorrect, say scientists

Apply to Attend the ACR’s Advocates for Arthritis Day

Staff  |  June 1, 2013

Event educates legislators about the impact of rheumatic diseases and the importance of care provided by rheumatology professionals

  • « Previous Page
  • 1
  • …
  • 240
  • 241
  • 242
  • 243
  • 244
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences